|
When to use Human Challenge Models and Controlled Human Infection Models
|
|
0
|
6
|
February 19, 2025
|
|
Is the drug that I want to prescribe reimbursed?
|
|
1
|
24
|
February 18, 2025
|
|
Dutch ATMP summit
|
|
0
|
19
|
December 12, 2024
|
|
Is there a overview of tools, methods and database that can be used for Drug Repurposing?
|
|
3
|
27
|
February 17, 2025
|
|
iDR25 - Pre-Conference Workshops (Brussels)
|
|
1
|
15
|
February 17, 2025
|
|
Succesvolle voorbeelden van drug repurposing? / Examples of successful drug repurposing?
|
|
1
|
23
|
February 17, 2025
|
|
Funding opportunities for drug repurposing
|
|
5
|
89
|
February 17, 2025
|
|
CAT template examples
|
|
2
|
64
|
February 14, 2025
|
|
Exploring Academic ATMP Development: Insights from Belgium & Comparisons with the Netherlands
|
|
0
|
13
|
February 14, 2025
|
|
Patient recorded outcome measurements (PROMs) for rare diseases
|
|
1
|
18
|
February 13, 2025
|
|
Orphan Drug designation
|
|
2
|
42
|
February 6, 2025
|
|
EU HTA regulation impact and ATMP market access?
|
|
0
|
20
|
February 5, 2025
|
|
Patientregistries on rare disease
|
|
4
|
20
|
February 4, 2025
|
|
Difference Orphan designation and marketing authorisation
|
|
1
|
42
|
February 4, 2025
|
|
Current and Innovative Radionuclides for Medical Imaging and Therapy | PRISMAP School
|
|
0
|
8
|
January 31, 2025
|
|
Financiering voor onderzoek naar gepast gebruik / Funding for research on optimizing medication use
|
|
1
|
21
|
January 28, 2025
|
|
Open Academy Schools | EURODIS
|
|
0
|
5
|
January 27, 2025
|
|
Rare2025 | Vienna, Austria
|
|
0
|
16
|
January 24, 2025
|
|
How do you define if something really is repurposing and not drug ever-greening?
|
|
2
|
48
|
January 24, 2025
|
|
Regulatory expectations for potency assays
|
|
0
|
23
|
January 23, 2025
|
|
Patient limits for Hospital Exemption in the Netherlands
|
|
2
|
64
|
January 21, 2025
|
|
Nationale Conferentie Zeldzame Aandoeningen 2025 | VSOP & NFU
|
|
0
|
12
|
January 17, 2025
|
|
Where can I find an overview of the steps needed to develop a repurposed drug?
|
|
2
|
29
|
January 14, 2025
|
|
Zeldzameziektendag NL
|
|
0
|
8
|
January 10, 2025
|
|
EANM 2025 - Barcalona
|
|
0
|
9
|
January 9, 2025
|
|
iDR25 - Medicines Reimagined: Unlocking the potential of existing drugs for patient benefit (Brussels)
|
|
0
|
15
|
January 8, 2025
|
|
What are the expected changes in the revision of the EMA guideline on radiopharmaceuticals?
|
|
0
|
25
|
August 28, 2024
|
|
World Vaccine Congress Europe - Amsterdam
|
|
0
|
5
|
January 7, 2025
|
|
FDA-NIH Rare disease day, USA - February 27-28
|
|
0
|
7
|
January 7, 2025
|
|
1e Nederlandse Vaccinatie Dag - Amersfoort
|
|
0
|
4
|
December 17, 2024
|